Intravenous Immunoglobulin (IVIg) Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Intravenous Immunoglobulin (IVIg) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.5% during the forecast period.

    This report presents the market size and development trends by detailing the Intravenous Immunoglobulin (IVIg) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Intravenous Immunoglobulin (IVIg) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Intravenous Immunoglobulin (IVIg) industry and will help you to build a panoramic view of the industrial development.

    Intravenous Immunoglobulin (IVIg) Market, By Type:

    • IVIg Liquid

    • IVIg Powder

    Intravenous Immunoglobulin (IVIg) Market, By Application:

    • Immunodeficiency

    • Autoimmune Disease

    • Acute Infection

    Some of the leading players are as follows:

    • Baxter

    • CSL

    • LFB Group

    • Sichuan Yuanda Shuyang

    • Shanghai RAAS

    • Hualan Bio

    • Biotest

    • BPL

    • Kedrion

    • CNBG

    • Grifols

    • Octapharma

    • CBPO

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Intravenous Immunoglobulin (IVIg) Market: Technology Type Analysis

    • 4.1 Intravenous Immunoglobulin (IVIg) Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Intravenous Immunoglobulin (IVIg) Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 IVIg Liquid

      • 4.3.2 IVIg Powder

    5 Intravenous Immunoglobulin (IVIg) Market: Product Analysis

    • 5.1 Intravenous Immunoglobulin (IVIg) Product Market Share Analysis, 2018 & 2026

    • 5.2 Intravenous Immunoglobulin (IVIg) Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Intravenous Immunoglobulin (IVIg) Market: Application Analysis

    • 6.1 Intravenous Immunoglobulin (IVIg) Application Market Share Analysis, 2018 & 2026

    • 6.2 Intravenous Immunoglobulin (IVIg) Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Immunodeficiency

      • 6.3.2 Autoimmune Disease

      • 6.3.3 Acute Infection

    7 Intravenous Immunoglobulin (IVIg) Market: Regional Analysis

    • 7.1 Intravenous Immunoglobulin (IVIg) Regional Market Share Analysis, 2018 & 2026

    • 7.2 Intravenous Immunoglobulin (IVIg) Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Baxter

      • 9.1.1 Baxter Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 CSL

      • 9.2.1 CSL Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 LFB Group

      • 9.3.1 LFB Group Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Sichuan Yuanda Shuyang

      • 9.4.1 Sichuan Yuanda Shuyang Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Shanghai RAAS

      • 9.5.1 Shanghai RAAS Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Hualan Bio

      • 9.6.1 Hualan Bio Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Biotest

      • 9.7.1 Biotest Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 BPL

      • 9.8.1 BPL Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Kedrion

      • 9.9.1 Kedrion Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 CNBG

      • 9.10.1 CNBG Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Grifols

      • 9.11.1 Grifols Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Octapharma

      • 9.12.1 Octapharma Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 CBPO

      • 9.13.1 CBPO Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

     

    The List of Tables and Figures (Totals 112 Figures and 124 Tables)

    • Figure IVIg Liquid Intravenous Immunoglobulin (IVIg) market, 2015 - 2026 (USD Million)

    • Figure IVIg Powder Intravenous Immunoglobulin (IVIg) market, 2015 - 2026 (USD Million)

    • Figure Immunodeficiency market, 2015 - 2026 (USD Million)

    • Figure Autoimmune Disease market, 2015 - 2026 (USD Million)

    • Figure Acute Infection market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Intravenous Immunoglobulin (IVIg) market, by country, 2015 - 2026 (USD Million)

    • Table North America Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table North America Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table North America Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table Canada Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table Canada Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Europe Intravenous Immunoglobulin (IVIg) market, by country, 2015 - 2026 (USD Million)

    • Table Europe Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table Europe Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table Europe Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table Germany Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table Germany Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table France Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table France Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table Italy Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table Italy Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table Spain Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table Spain Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table China Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table China Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table Japan Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table Japan Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table India Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table India Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Intravenous Immunoglobulin (IVIg) market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table MEA Intravenous Immunoglobulin (IVIg) market, by country, 2015 - 2026 (USD Million)

    • Table MEA Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table MEA Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table MEA Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Intravenous Immunoglobulin (IVIg) market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Intravenous Immunoglobulin (IVIg) market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Intravenous Immunoglobulin (IVIg) market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Baxter Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CSL Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table LFB Group Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sichuan Yuanda Shuyang Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Shanghai RAAS Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Hualan Bio Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Biotest Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BPL Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Kedrion Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CNBG Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Grifols Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Octapharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CBPO Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.